In last trading session, HCW Biologics Inc (NASDAQ:HCWB) saw 0.36 million shares changing hands with its beta currently measuring 0.91. Company’s recent per share price level of $0.45 trading at $0.04 or 8.72% at ring of the bell on the day assigns it a market valuation of $16.98M. That closing price of HCWB’s stock is at a discount of -460.0% from its 52-week high price of $2.52 and is indicating a premium of 37.78% from its 52-week low price of $0.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.4 million shares which gives us an average trading volume of 9.21 million if we extend that period to 3-months.
HCW Biologics Inc (NASDAQ:HCWB) trade information
HCW Biologics Inc’s shares saw a change of -63.35% in year-to-date performance and have moved 25.77% in past 5-day. HCW Biologics Inc (NASDAQ:HCWB) showed a performance of -52.60% in past 30-days. Number of shares sold short was 8092.0 shares which calculate 0.28 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HCW Biologics Inc (HCWB) estimates and forecasts
This year revenue growth is estimated to rise 222.75% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 7M for the same.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -34.57% during past 5 years.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
Insiders are in possession of 52.30% of company’s total shares while institution are holding 3.13 percent of that, with stock having share float percentage of 6.56%. Investors also watch the number of corporate investors in a company very closely, which is 3.13% institutions for HCW Biologics Inc that are currently holding shares of the company. AVANTAX PLANNING PARTNERS, INC. is the top institutional holder at HCWB for having 0.28 million shares of worth $0.18 million. And as of 2024-06-30, it was holding 0.751 of the company’s outstanding shares.
The second largest institutional holder is HIGHTOWER ADVISORS, LLC, which was holding about 0.18 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.4857 of outstanding shares, having a total worth of $0.12 million.
